Suchergebnisse - "COVID‐19 Therapies"

Predictors of inpatient outcomes of COVID‐19 infection in patients with cirrhosis in the early pandemic phase: A nationwide survey

Autoren: Abdullah Sohail Khadija Naseem Ahmad Khan et al.

Quelle: JGH Open
JGH Open, Vol 7, Iss 12, Pp 889-898 (2023)

Schlagwörter: resource utilization, Advanced COVID‐19 therapies, chronic liver disease, RC799-869, Original Articles, Diseases of the digestive system. Gastroenterology, inpatient mortality, National Inpatient Sample database, 3. Good health

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38162845
https://doaj.org/article/4288ce125cc3496da361413729d4ab21

The impact of early therapies for COVID-19 on death, hospitalization and persisting symptoms: a retrospective study

Autoren: Bertuccio, Paola Degli Antoni, Melania Minisci, Davide et al.

Weitere Verfasser: Bertuccio, Paola Degli Antoni, Melania Minisci, Davide et al.

Quelle: Infection

Schlagwörter: Male, Long COVID, Monoclonal antibodie, Ritonavir, PCC, SARS-CoV-2, Research, COVID-19, Antibodies, Monoclonal, Antibodies, Viral, Antiviral Agents, Early COVID-19 therapie, 3. Good health, Hospitalization, Post-Acute COVID-19 Syndrome, Antivirals, Early COVID-19 therapies, Monoclonal antibodies, Secondary Prevention, Humans, Female, Antiviral, Retrospective Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37024626

Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

Autoren: Vale, Claire Godolphin, Peter J Fisher, David et al.

Quelle: The Lancet Diabetes & Endocrinology , 12 (10) pp. 735-747. (2024)

Schlagwörter: WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group

Dateibeschreibung: text

Relation: https://discovery.ucl.ac.uk/id/eprint/10197619/1/PIIS2213858724002195.pdf; https://discovery.ucl.ac.uk/id/eprint/10197619/

Verfügbarkeit: https://discovery.ucl.ac.uk/id/eprint/10197619/1/PIIS2213858724002195.pdf
https://discovery.ucl.ac.uk/id/eprint/10197619/

Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants

Autoren: Anzalone, A. Jerrod Beasley, William H. Murray, Kimberly et al.

Quelle: School of Medicine Faculty Publications

Schlagwörter: COVID-19 Therapies, Mortality, National COVID Cohort Collaborative (N3C), SARS-CoV-2, Urban-Rural Health, COVID-19, Genetics, Public Health Education and Promotion

Dateibeschreibung: application/pdf

Relation: https://digitalscholar.lsuhsc.edu/som_facpubs/2862; https://digitalscholar.lsuhsc.edu/context/som_facpubs/article/3864/viewcontent/AssociationsBetweenCovid19TherapiesAndOutcomesInRuralAndUrbanAmerica_2024.pdf

Verfügbarkeit: https://digitalscholar.lsuhsc.edu/som_facpubs/2862
https://doi.org/10.1111/jrh.12857
https://digitalscholar.lsuhsc.edu/context/som_facpubs/article/3864/viewcontent/AssociationsBetweenCovid19TherapiesAndOutcomesInRuralAndUrbanAmerica_2024.pdf

INTENSIVE CARE UNIT MANAGEMENT OF SARS-COV-2 PATIENTS: A NARRATIVE REVIEW

Autoren: Taimoor Hassan Sana Saeed Sidra Naseem et al.

Quelle: Gomal Journal of Medical Sciences, Vol 19, Iss 4, Pp 152-156 (2022)

Schlagwörter: 03 medical and health sciences, covid-19 therapies, 0302 clinical medicine, covid-19 pandemic, Medicine, health hazards, acute respiratory distress syndrome, 3. Good health

Zugangs-URL: http://www.gjms.com.pk/index.php/journal/article/download/1024/pdf
https://doaj.org/article/5f1916afb9724175b60a6cde8690570f

A Review of Candidate Therapies for Beta Coronavirus a Molecular Research

Autoren: Aili Lyu Fatema Bassam Ahmed

Quelle: Asian Pacific Journal of Cancer Care, Vol 6, Iss S1, Pp 83-86 (2021)

Schlagwörter: 03 medical and health sciences, 0302 clinical medicine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, viral infection, covid-19, therapies and vaccination, mers-cov, interferon, dpp4, betacoronavirus, rna virus, sars-cov, sars-cov-2, RC254-282, 3. Good health

Zugangs-URL: http://www.waocp.com/journal/index.php/apjcc/article/download/700/1803
https://doaj.org/article/fb702c7ba4834519af4454f9b278f30e

In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches

Autoren: Mahmoud A. El Hassab Tamer M. Ibrahim Sara T. Al‐Rashood et al.

Quelle: J Enzyme Inhib Med Chem
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 727-736 (2021)

Schlagwörter: Protein Conformation, alpha-Helical, 0301 basic medicine, Computational chemistry, Adenosine, Databases, Pharmaceutical, Infectious disease (medical specialty), FOS: Health sciences, Crystallography, X-Ray, Biochemistry, Gene, mm-pbsa calculations, Computational biology, Druggability, Drug Stability, Secondary Structure Prediction, Pathology, Disease, Enzyme Inhibitors, Databases, Protein, Ribosome Structure and Translation Mechanisms, Methyltransferase, Drug discovery, Life Sciences, 3d pharmacophore, 3. Good health, Molecular Docking Simulation, Chemistry, Computational Theory and Mathematics, Physical Sciences, Thermodynamics, Medicine, Research Paper, Protein Binding, Computational Methods in Drug Discovery, Virtual screening, Docking (animal), RM1-950, Nursing, Molecular Dynamics Simulation, Molecular dynamics, Antiviral Agents, Methylation, 03 medical and health sciences, sars cov-2 2′-o-methyltransferase (nsp16) inhibitor, Biochemistry, Genetics and Molecular Biology, Humans, Protein Interaction Domains and Motifs, Molecular Biology, Biology, O-methyltransferase, Binding Sites, Protein Structure Prediction and Analysis, Pharmacophore, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), In silico, Protein Data Bank (RCSB PDB), Methyltransferases, molecular dynamics, High-Throughput Screening Assays, Coronavirus disease 2019 (COVID-19), Kinetics, covid-19 therapies, Enzyme, Computer Science, Protein Conformation, beta-Strand, Therapeutics. Pharmacology

Zugangs-URL: https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1885396?needAccess=true
https://pubmed.ncbi.nlm.nih.gov/33685335
https://doaj.org/article/98234b16b4e14c1eaae68e930447cbd7
https://europepmc.org/article/PMC/PMC7946047
https://pubmed.ncbi.nlm.nih.gov/33685335/
https://www.tandfonline.com/doi/full/10.1080/14756366.2021.1885396
https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/zh/covidwho-1123193
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946047

COVID-19 therapies: do we see substantial progress?

Autoren: Lucyna Matusewicz Marlena Golec Aleksander Czogalla et al.

Quelle: Cellular & Molecular Biology Letters, Vol 27, Iss 1, Pp 1-26 (2022)

Schlagwörter: ACE2: coronaviruses, COVID-19, COVID-19 therapies, SARS-CoV-2, Cytology, QH573-671

Dateibeschreibung: electronic resource

Relation: https://doaj.org/toc/1425-8153; https://doaj.org/toc/1689-1392

Zugangs-URL: https://doaj.org/article/52bf6eda2d9a4fab9e9b1c4265201fff

INTENSIVE CARE UNIT MANAGEMENT OF SARS-COV-2 PATIENTS: A NARRATIVE REVIEW

Autoren: Taimoor Hassan Sana Saeed Sidra Naseem et al.

Quelle: Gomal Journal of Medical Sciences, Vol 19, Iss 4, Pp 152-156 (2022)

Schlagwörter: acute respiratory distress syndrome, covid-19 pandemic, covid-19 therapies, health hazards., Medicine

Dateibeschreibung: electronic resource

Relation: http://gjms.com.pk/index.php/journal/article/view/1024; https://doaj.org/toc/1819-7973; https://doaj.org/toc/1997-2067

Zugangs-URL: https://doaj.org/article/5f1916afb9724175b60a6cde8690570f

Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants

Autoren: Anzalone, A Jerrod Beasley, William H Murray, Kimberly et al.

Quelle: MaineHealth Maine Medical Center

Schlagwörter: COVID‐19 Therapies, Mortality, National COVID Cohort Collaborative (N3C), SARS‐CoV‐2, Urban‐Rural Health, Humans, Male, Female, SARS-CoV-2, COVID-19 (epidemiology, prevention & control, mortality), Urban Population (statistics & numerical data), Retrospective Studies, Rural Population (statistics & numerical data), Middle Aged, United States (epidemiology), Aged, Adult, COVID-19 Drug Treatment, Antiviral Agents (therapeutic use), Hospitalization (statistics & numerical data), COVID-19 Vaccines (therapeutic use, administration & dosage)

Relation: https://knowledgeconnection.mainehealth.org/mmc/3888; https://pubmed.ncbi.nlm.nih.gov/38953158/

Verfügbarkeit: https://knowledgeconnection.mainehealth.org/mmc/3888
https://pubmed.ncbi.nlm.nih.gov/38953158/

Discovery of a bradykinin b2 partial agonist profile of raloxifene in a drug repurposing campaign

Autoren: Gómez Gutiérrez, Patricia Pérez González, Juan Jesús Universitat Politècnica de Catalunya. Doctorat en Polímers i Biopolímers et al.

Weitere Verfasser: Gómez Gutiérrez, Patricia Pérez González, Juan Jesús Universitat Politècnica de Catalunya. Doctorat en Polímers i Biopolímers et al.

Schlagwörter: Àrees temàtiques de la UPC::Enginyeria química::Biotecnologia, COVID-19 (Disease), Drugs, Nonpeptide bradykinin partial agonist, Drug repurposing, Covid-19 therapies, Raloxifene, COVID-19 (Malaltia), Medicaments

Dateibeschreibung: application/pdf

Relation: https://www.mdpi.com/1422-0067/22/1/257; http://hdl.handle.net/2117/341999

Verfügbarkeit: http://hdl.handle.net/2117/341999
https://doi.org/10.3390/ijms22010257

Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?

Autoren: Pedro Castro Marta Palomo Ana Belen Moreno-Castaño et al.

Quelle: Cardiovasc Drugs Ther
Cardiovascular Drugs and Therapy
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Institut de Recerca Germans Trias i Pujol (IGTP)

Schlagwörter: Complement system, SARS-CoV-2, COVID-19, Endothelial Cells, Review Article, Endotheliopathy, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Coagulopathy, Endothelial protection, COVID-19 therapies, Humans, Endothelium, Endothelium, Vascular, Vascular Diseases, Cytokine Release Syndrome

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s10557-021-07207-w.pdf
https://pubmed.ncbi.nlm.nih.gov/34097193
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4538
https://pubmed.ncbi.nlm.nih.gov/34097193/
https://link.springer.com/article/10.1007%2Fs10557-021-07207-w
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181544
https://europepmc.org/article/MED/34097193
http://www.ncbi.nlm.nih.gov/pubmed/34097193
https://link.springer.com/content/pdf/10.1007/s10557-021-07207-w.pdf

Discovery of a bradykinin b2 partial agonist profile of raloxifene in a drug repurposing campaign

Autoren: Universitat Politècnica de Catalunya. Doctorat en Polímers i Biopolímers Universitat Politècnica de Catalunya. Departament d'Enginyeria Química Universitat Politècnica de Catalunya. GBMI - Grup de Biotecnologia Molecular i Industrial et al.

Index Begriffe: Àrees temàtiques de la UPC::Enginyeria química::Biotecnologia, COVID-19 (Disease), Drugs, Nonpeptide bradykinin partial agonist, Drug repurposing, Covid-19 therapies, Raloxifene, COVID-19 (Malaltia), Medicaments, Article

URL: http://hdl.handle.net/2117/341999
https://www.mdpi.com/1422-0067/22/1/257
https://www.mdpi.com/1422-0067/22/1/257

Current clinical status of new COVID-19 vaccines and immunotherapy.

Autoren: Nagpal D Nagpal S Kaushik D et al.

Quelle: Environmental science and pollution research international [Environ Sci Pollut Res Int] 2022 Oct; Vol. 29 (47), pp. 70772-70807. Date of Electronic Publication: 2022 Sep 05.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Springer Country of Publication: Germany NLM ID: 9441769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1614-7499 (Electronic) Linking ISSN: 09441344 NLM ISO Abbreviation: Environ Sci Pollut Res Int Subsets: MEDLINE

MeSH-Schlagworte: COVID-19*/prevention & control , Vaccines*, COVID-19 Vaccines ; Humans ; Immunotherapy ; RNA ; SARS-CoV-2

Computational Prediction of the Potential Target of SARS-CoV-2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM-PBSA Calculations.

Autoren: El Hassab MA Hemeda LR Elsayed ZM et al.

Quelle: Chemistry & biodiversity [Chem Biodivers] 2022 Feb; Vol. 19 (2), pp. e202100719. Date of Electronic Publication: 2022 Jan 04.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Verlag Helvetica Chimica Acta Country of Publication: Switzerland NLM ID: 101197449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1612-1880 (Electronic) Linking ISSN: 16121872 NLM ISO Abbreviation: Chem Biodivers Subsets: MEDLINE

MeSH-Schlagworte: Antiviral Agents*/chemistry , SARS-CoV-2*/drug effects, Depsipeptides/*chemistry , Peptides, Cyclic/*chemistry, COVID-19 ; Humans ; Molecular Docking Simulation ; Molecular Dynamics Simulation

Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.

Autoren: Sahana S Sivadas A Mangla M et al.

Quelle: Pharmacogenomics [Pharmacogenomics] 2021 Jul; Vol. 22 (10), pp. 603-618. Date of Electronic Publication: 2021 Jun 18.

Publikationsart: Journal Article; Research Support, Non-U.S. Gov't

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE

MeSH-Schlagworte: COVID-19 Drug Treatment*, COVID-19/*genetics, Antiviral Agents/therapeutic use ; Asian People ; Drug Interactions/genetics ; Genome/genetics ; Genotype ; Humans ; India ; Pharmacogenetics/methods ; Pharmacogenomic Testing/methods ; Pharmacogenomic Variants/genetics ; SARS-CoV-2/drug effects

Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic.

Autoren: Bariola JR McCreary EK Khadem T et al.

Quelle: Open forum infectious diseases [Open Forum Infect Dis] 2021 Mar 26; Vol. 8 (7), pp. ofab151. Date of Electronic Publication: 2021 Mar 26 (Print Publication: 2021).

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.

Autoren: Najar Nobari N Seirafianpour F Mashayekhi F et al.

Quelle: Dermatologic therapy [Dermatol Ther] 2021 Jan; Vol. 34 (1), pp. e14662. Date of Electronic Publication: 2020 Dec 26.

Publikationsart: Journal Article; Systematic Review

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-8019 (Electronic) Linking ISSN: 13960296 NLM ISO Abbreviation: Dermatol Ther Subsets: MEDLINE

MeSH-Schlagworte: COVID-19*/therapy, Antiviral Agents/*adverse effects , Skin Diseases/*chemically induced, Humans ; Hydroxychloroquine ; Pandemics ; SARS-CoV-2